Skip to content

Evaluation of a Ionic Silver and Honey Preparation to Treat Chronic Wounds of the Lower Legs

Open Label Study (Phase 2) to Evaluate the Safety, Tolerance and Efficacy of a Ionic Silver and Honey Preparation to Treat Chronic Wounds of the Lower Legs

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01111695
Enrollment
30
Registered
2010-04-27
Start date
2010-01-31
Completion date
2010-11-30
Last updated
2011-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leg Ulcer

Keywords

wound healing, granulation tissue, Varicose Ulcer

Brief summary

In this open study, the primary objective is to study the efficacy and clinical outcome of the chronic wounds treated with this preparation for 8 weeks on 30 adults. Evaluation will be based on standardised photographs and clinical data. The secondary objectives are to evaluate the tolerance and side effects of the honey based preparation in the management of chronic wounds.

Interventions

DEVICEApisSept

honey and ionic silver based dressing

Sponsors

Haute école de santé - Genève
CollaboratorUNKNOWN
University Hospital, Geneva
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult * Chronic wounds due to arterial or venous insufficiency stages 1 to 3 and difficult to heal with the usual treatments and * Written informed consent

Exclusion criteria

* Refuse to give written informed consent. * Patient suffering from mental disorder that may interfere with the treatment. * Known allergy or intolerance to any of the products used in the formulation. * Having received systemic antibiotics within 7 days of starting treatment with honey based formulation. * Arterial insufficiency stage IV of the lower limbs.

Design outcomes

Primary

MeasureTime frameDescription
Granulation and /or epithelial tissue progression8 weeksGranulation and /or epithelial tissue progression as observed by standardised photography (colour-based and analysis of the wound).

Secondary

MeasureTime frameDescription
Tolerance8 weeksTolerance: Evaluate for signs and symptoms of irritation,inflammation, allergy or pain in and around the treated zone by clinical observation.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026